Gensaic: Funding, Investors & Team (Oct 2026)
A biotechnology startup called Gensaic (formerly M13Tx) is creating a phage-derived particle (PDP) gene delivery platform to address some of the major issues with the gene therapy market today. PDPs enable tissue-specific targeting, permit massively scalable manufacture, and may package any full-length human gene as a therapeutic (>20 kb). They also provide lasting therapeutic efficacy through repeated delivery. Delivering any therapeutic gene to any target cell is Gensaic's goal.
Gensaic has raised $3.5M across 1 funding round on record, the most recent an undisclosed round of $3.5M announced in Jan 2023.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Gensaic Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Gensaic Funding Rounds
Gensaic Founders and Leadership Team
Contact details for the Gensaic team: 1 of 1 has an email address on file.
Start 14-day free trial →Gensaic Funding Compared to Other Health Care Startups
Gensaic's latest round of $3.5M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gensaic in Health Care and Cambridge
Companies Similar to Gensaic
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Gensaic Funding FAQs
What does Gensaic do?
A biotechnology startup called Gensaic (formerly M13Tx) is creating a phage-derived particle (PDP) gene delivery platform to address some of the major issues with the gene therapy market today. PDPs enable tissue-specific targeting, permit massively scalable manufacture, and may package any full-length human gene as a therapeutic (>20 kb). They also provide lasting therapeutic efficacy through repeated delivery. Delivering any therapeutic gene to any target cell is Gensaic's goal.
How much funding has Gensaic raised?
Gensaic has raised $3.5M across 1 round on record. The most recent is an undisclosed round of $3.5M announced in Jan 2023.
When did Gensaic last raise funding?
Gensaic's most recent funding round on record is an undisclosed round of $3.5M, announced in Jan 2023.
Who is the CEO of Gensaic?
Lavi Erisson is listed as CEO at Gensaic.
Where is Gensaic headquartered?
Gensaic is based in Cambridge, Massachusetts, United States.
How many employees does Gensaic have?
Gensaic is in the 1-10 employee band.
How does Gensaic's funding compare to other Health Care startups?
Gensaic's latest round of $3.5M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Gensaic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gensaic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.